Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
AMETEK Inc is a specialty industrial machinery business based in the US. AMETEK shares (AME) are listed on the NYSE and all prices are listed in US Dollars. AMETEK employs 16,500 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$129.24|
|52-week range||$94.31 - $139.89|
|50-day moving average||$135.22|
|200-day moving average||$132.80|
|Wall St. target price||$158.47|
|Dividend yield||$0.76 (0.57%)|
|Earnings per share (TTM)||$3.77|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||-0.69%|
|1 month (2021-08-24)||-5.03%|
|3 months (2021-06-24)||-3.29%|
|6 months (2021-03-24)||5.24%|
|1 year (2020-09-24)||34.30%|
|2 years (2019-09-24)||43.79%|
|3 years (2018-09-24)||60.47%|
|5 years (2016-09-23)||172.83%|
Valuing AMETEK stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AMETEK's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AMETEK's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, AMETEK shares trade at around 35x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
AMETEK's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0287. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into AMETEK's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
AMETEK's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.4 billion.
The EBITDA is a measure of a AMETEK's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.9 billion|
|Operating margin TTM||23.51%|
|Gross profit TTM||$1.6 billion|
|Return on assets TTM||6.56%|
|Return on equity TTM||14.82%|
|Market capitalisation||$30.1 billion|
TTM: trailing 12 months
There are currently 1.7 million AMETEK shares held short by investors – that's known as AMETEK's "short interest". This figure is 4% up from 1.7 million last month.
There are a few different ways that this level of interest in shorting AMETEK shares can be evaluated.
AMETEK's "short interest ratio" (SIR) is the quantity of AMETEK shares currently shorted divided by the average quantity of AMETEK shares traded daily (recently around 750679.39914163). AMETEK's SIR currently stands at 2.33. In other words for every 100,000 AMETEK shares traded daily on the market, roughly 2330 shares are currently held short.
However AMETEK's short interest can also be evaluated against the total number of AMETEK shares, or, against the total number of tradable AMETEK shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AMETEK's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 AMETEK shares in existence, roughly 10 shares are currently held short) or 0.0076% of the tradable shares (for every 100,000 tradable AMETEK shares, roughly 8 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AMETEK.
Find out more about how you can short AMETEK stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like AMETEK.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 33.32
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and AMETEK's overall score of 33.32 (as at 12/31/2018) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like AMETEK is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 10.08/100
AMETEK's environmental score of 10.08 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that AMETEK is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 15.44/100
AMETEK's social score of 15.44 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that AMETEK is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 8.8/100
AMETEK's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that AMETEK is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. AMETEK scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that AMETEK has, for the most part, managed to keep its nose clean.
|Total ESG score||33.32|
|Total ESG percentile||56.8|
|Environmental score percentile||5|
|Social score percentile||5|
|Governance score percentile||5|
|Level of controversy||2|
Dividend payout ratio: 18.1% of net profits
Recently AMETEK has paid out, on average, around 18.1% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.6% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), AMETEK shareholders could enjoy a 0.6% return on their shares, in the form of dividend payments. In AMETEK's case, that would currently equate to about $0.76 per share.
While AMETEK's payout ratio might seem low, this can signify that AMETEK is investing more in its future growth.
AMETEK's most recent dividend payout was on 29 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 12 September 2021 (the "ex-dividend date").
AMETEK's shares were split on a 3:2 basis on 1 July 2012. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your AMETEK shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for AMETEK shares which in turn could have impacted AMETEK's share price.
Over the last 12 months, AMETEK's shares have ranged in value from as little as $94.3116 up to $139.8851. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while AMETEK's is 1.3346. This would suggest that AMETEK's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices worldwide. It operates in two segments, Electronic Instruments (EIG) and Electromechanical (EMG). The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets. This segment also provides power quality monitoring and metering devices, uninterruptible power supplies, programmable power equipment, electromagnetic compatibility test equipment, sensors for gas turbines, dashboard instruments for heavy trucks and other vehicles, and instrumentation and controls for the food and beverage industries; and aircraft and engine sensors, monitoring systems, power supplies, fuel and fluid measurement systems, and data acquisition units for the aerospace industry. Its EMG segment offers engineered electrical connectors and electronics packaging for protecting sensitive electronic devices; precision motion control products for data storage, medical devices, business equipment, automation and other applications; high-purity powdered metals, strip and foil, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for use in thermal management, military, commercial aircraft, and military ground vehicles; and motors for use in commercial appliances, fitness equipment, food and beverage machines, hydraulic pumps, and industrial blowers. This segment also operates a network of aviation maintenance, repair, and overhaul facilities.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
Everything we know about the MiNK Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.